Open original FDA record ↗Recall record
- FDA identifier
- Z-0958-2007
- Company in FDA record
- Abbott Diagnostic International, Ltd.
- FDA classification date
- Jul 3, 2007
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
A decrease in mP values (calibration curve Net Polarization value) has been observed with this reagent lot at all calibrator levels and may produce the following results: Calibration Error Code 148 (Polarization Too Small), Calibration Error Code 172 (Calibration Not Stored or Calibration Not Accepted) Controls out of range (when using a stored calibration curve).
Source facts
- Action
- An April 11, 2007, Product Recall Letter was sent to all customers who received the affected lot. All customers who received the affected lot will be contacted. The following communication types were used: Product Recall Letter & Customer Reply Form. Letters were sent to customers by Federal Express Priority mail. The Customers were instructed the following: To discontinue use of and destroy IMx Theophylline reagent lot 41610QI00. If they had forwarded the lots listed in the Product Recall letter to other laboratories, they were instructed to inform them of this Product Recall and provide a copy of this letter to them. They also we instructed to retain a copy of the communication for their records
- Initiated
- 2007-04-11
- Root cause
- Other
- Terminated
- 2011-06-10
- Distribution
- Worldwide: CA, IL, MA, NY, OR, PA, VA, and WV and countries of Germany and Singapore
- Recall number
- Z-0958-2007
- Recall status
- Terminated
- CDRH record ID
- 52441
- FDA classified
- 2007-07-03
- Recall event number
- 37957